Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,245 | 65 | 98.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $17.90 | 1 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $511.58 | 21 | $0 (2022) |
| Merz North America, Inc. | $109.15 | 4 | $0 (2019) |
| US WorldMeds, LLC | $105.26 | 9 | $0 (2017) |
| Ipsen Biopharmaceuticals, Inc | $99.08 | 5 | $0 (2020) |
| ABBVIE INC. | $75.29 | 4 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $56.78 | 5 | $0 (2018) |
| Merz Pharmaceuticals, LLC | $44.75 | 1 | $0 (2021) |
| GENZYME CORPORATION | $44.74 | 3 | $0 (2020) |
| Depomed, Inc. | $29.67 | 2 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $27.86 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $36.32 | 2 | ABBVIE INC. ($36.32) |
| 2023 | $37.27 | 2 | Medtronic, Inc. ($20.65) |
| 2022 | $66.46 | 3 | Allergan, Inc. ($44.11) |
| 2021 | $63.54 | 2 | Merz Pharmaceuticals, LLC ($44.75) |
| 2020 | $60.78 | 3 | Ipsen Biopharmaceuticals, Inc ($21.33) |
| 2019 | $244.12 | 13 | Allergan Inc. ($98.67) |
| 2018 | $171.94 | 11 | Allergan Inc. ($57.26) |
| 2017 | $582.73 | 30 | Allergan Inc. ($274.08) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 2 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2018 | SI-BONE, Inc. | iFuse Implant (Device) | Food and Beverage | Cash or cash equivalent | $15.17 | General |
| Category: sacroiliac joint dysfunction | ||||||
| 12/04/2018 | GENZYME CORPORATION | LUMIZYME (Drug), POMPE - DISEASE | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: RARE DISEASE GENETICS | ||||||
| 11/07/2018 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Neurology | ||||||
| 10/09/2018 | Allergan Inc. | BOTOX - SPASTICITY (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: SPASTICITY | ||||||
| 08/29/2018 | Impax Laboratories, Inc. | RYTARY (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: NEUROLOGY | ||||||
| 08/23/2018 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 06/26/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.65 | General |
| Category: Cardiovascular | ||||||
| 06/14/2018 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/23/2018 | Allergan Inc. | BOTOX - NEUROLOGY (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2018 | GENZYME CORPORATION | LUMIZYME (Drug), POMPE - DISEASE | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: RARE DISEASE GENETICS | ||||||
| 01/11/2018 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: HYPERHYDROSIS | ||||||
| 09/14/2017 | Allergan Inc. | BOTOX NEURO REHAB (Drug) | Food and Beverage | In-kind items and services | $146.85 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2017 | US WorldMeds, LLC | Xadago (Drug), MYOBLOC, APOKYN | Food and Beverage | In-kind items and services | $4.57 | General |
| Category: Neurology | ||||||
| 08/21/2017 | Acorda Therapeutics, Inc | AMPYRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $17.90 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 08/11/2017 | Allergan Inc. | BOTOX CHRONIC MIGRAINE (Drug) | Food and Beverage | In-kind items and services | $9.89 | General |
| Category: ANTI-MIGRAINE | ||||||
| 07/27/2017 | US WorldMeds, LLC | Xadago (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Neurology | ||||||
| 07/17/2017 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.93 | General |
| 07/10/2017 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: PDP | ||||||
| 06/15/2017 | US WorldMeds, LLC | APOKYN (Drug), MYOBLOC | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Neurology | ||||||
| 06/12/2017 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $10.44 | General |
| Category: PDP | ||||||
| 06/01/2017 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Food and Beverage | Cash or cash equivalent | $29.64 | General |
| Category: Musculoskeletal | ||||||
| 05/31/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.21 | General |
| Category: Cardiovascular | ||||||
| 05/25/2017 | Depomed, Inc. | Nucynta (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Pain | ||||||
| 05/18/2017 | US WorldMeds, LLC | APOKYN (Drug), MYOBLOC | Food and Beverage | In-kind items and services | $7.35 | General |
| Category: Neurology | ||||||
| 05/10/2017 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.98 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 501 | 34,185 | $927,668 | $243,398 |
| 2022 | 19 | 569 | 25,323 | $763,686 | $194,539 |
| 2021 | 18 | 507 | 25,416 | $746,904 | $192,999 |
| 2020 | 18 | 470 | 24,802 | $715,163 | $176,511 |
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 46 | 33,195 | $564,315 | $163,757 | 29.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 63 | 179 | $41,528 | $16,621 | 40.0% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 19 | 57 | $83,160 | $8,370 | 10.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 116 | $19,720 | $7,881 | 40.0% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 43 | 103 | $21,939 | $6,065 | 27.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 46 | 46 | $16,790 | $5,845 | 34.8% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Office | 2023 | 20 | 41 | $20,377 | $5,546 | 27.2% |
| 64643 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Office | 2023 | 25 | 72 | $25,992 | $5,206 | 20.0% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Office | 2023 | 24 | 70 | $43,540 | $4,983 | 11.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 38 | 55 | $14,960 | $4,128 | 27.6% |
| 64646 | Injection of chemical for paralysis of nerve muscles on trunk, 1-5 muscles | Office | 2023 | 21 | 57 | $28,671 | $3,869 | 13.5% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 19 | 19 | $13,965 | $2,607 | 18.7% |
| 64645 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, each additional extremity | Office | 2023 | 12 | 23 | $8,970 | $2,153 | 24.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 22 | 39 | $4,524 | $1,666 | 36.8% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 12 | 12 | $5,436 | $1,244 | 22.9% |
| 98926 | Osteopathic manipulative treatment, 3-4 body regions | Office | 2023 | 13 | 35 | $4,865 | $1,225 | 25.2% |
| 95873 | Electrical stimulation for guidance with injection of chemical for paralysis of nerve muscle | Office | 2023 | 12 | 21 | $4,641 | $1,159 | 25.0% |
| 98925 | Osteopathic manipulative treatment, 1-2 body regions | Office | 2023 | 15 | 45 | $4,275 | $1,074 | 25.1% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 34 | 24,400 | $414,800 | $117,779 | 28.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 47 | 107 | $24,824 | $9,974 | 40.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 76 | 76 | $27,740 | $9,681 | 34.9% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2022 | 19 | 55 | $76,230 | $7,658 | 10.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 70 | 94 | $25,568 | $7,402 | 28.9% |
| 64643 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Office | 2022 | 25 | 73 | $26,353 | $5,373 | 20.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 72 | $12,240 | $4,841 | 39.6% |
About Dr. Li-Hong Lu, M.D
Dr. Li-Hong Lu, M.D is a Physical Medicine & Rehabilitation healthcare provider based in Wyomissing, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497713861.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Li-Hong Lu, M.D has received a total of $1,263 in payments from pharmaceutical and medical device companies, with $36.32 received in 2024. These payments were reported across 66 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,245).
As a Medicare-enrolled provider, Lu has provided services to 2,047 Medicare beneficiaries, totaling 109,726 services with total Medicare billing of $807,447. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Wyomissing, PA
- Active Since 05/03/2006
- Last Updated 05/15/2013
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1497713861
Products in Payments
- BOTOX (Biological) $231.15
- BOTOX NEURO REHAB (Drug) $193.72
- Xeomin (Biological) $106.50
- BOTOX (Drug) $81.08
- APOKYN (Drug) $57.21
- NUPLAZID (Drug) $56.78
- XEOMIN (Biological) $47.40
- DYSPORT (Drug) $40.32
- Dysport 300 U-1 (Drug) $37.05
- BOTOX THERAPEUTIC (Biological) $32.40
- Nucynta (Drug) $29.67
- MYOBLOC (Biological) $28.90
- ELIQUIS (Drug) $27.86
- LUMIZYME (Drug) $23.96
- Dysport (Drug) $21.71
- SYNCHROMEDII (Device) $20.65
- BOTOX - SPASTICITY (Drug) $20.13
- Xadago (Drug) $19.15
- SYNCHROMED (Device) $18.55
- BOTOX - NEUROLOGY (Drug) $18.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Wyomissing
Haiping Mei, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $1,696
Kelley Crozier, Md, MD
Physical Medicine & Rehabilitation — Payments: $730.41
Sanghoon Kim, Md, MD
Physical Medicine & Rehabilitation — Payments: $588.08
Paul Brockman, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $435.07
Somkiat Hemtasilpa, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $428.76
Mary Elmer
Physical Medicine & Rehabilitation — Payments: $215.26